KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Goodwill (2016 - 2026)

Idexx Laboratories has reported Goodwill over the past 17 years, most recently at $414.0 million for Q4 2025.

  • For Q4 2025, Goodwill rose 2.2% year-over-year to $414.0 million; the TTM value through Dec 2025 reached $414.0 million, up 2.2%, while the annual FY2025 figure was $414.0 million, 2.2% up from the prior year.
  • Goodwill for Q4 2025 was $414.0 million at Idexx Laboratories, roughly flat from $413.7 million in the prior quarter.
  • Over five years, Goodwill peaked at $414.5 million in Q2 2025 and troughed at $1.8 million in Q1 2021.
  • A 5-year average of $276.5 million and a median of $362.4 million in 2023 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: tumbled 98.45% in 2021 and later surged 19953.78% in 2022.
  • Year by year, Goodwill stood at $359.3 million in 2021, then crashed by 95.02% to $17.9 million in 2022, then skyrocketed by 1944.81% to $366.0 million in 2023, then increased by 10.68% to $405.1 million in 2024, then increased by 2.2% to $414.0 million in 2025.
  • Business Quant data shows Goodwill for IDXX at $414.0 million in Q4 2025, $413.7 million in Q3 2025, and $414.5 million in Q2 2025.